Industry Reports

Global Biosimulation Market Research And Analysis, 2015-2021

From $3,495.00

Report Code: HIT-1001 Categories: ,

Global Biosimulation Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2015-2021

Biosimulation Market Insights:

Global Biosimulation Market is predicted to grow significantly with a CAGR 15.5% during 2016-2021 due to rise in adoption of drug discovery and development and success in precision dosing. There are other pivotal factors that are driving the market which includes rising inclination towards personalized medicine, biomedicine and other research projects. Biosimulation applications such as preclinical testing, clinical trials, target identification and validation, lead identification and optimization are widely adopted. These applications enable to provide faster and more certain results compared to conventional techniques as a result it is widely adopted across the globe. The technological advancement and innovation in Biosimulation products and applications enable to reduce the number of clinical studies for drug development. Model-based drug development reduces the clinical studies and offer better results. Biosimulation have huge contribution in personalized medicines which are adopted widely for better patient care. Due to the advancement in biosimulation the traditional one size fits all concept is replaced by personalized medicines. Biosimulation models enable to find better protection against various diseases such as tumor and other cancer cases through precise dozing. As a result it saves time, effort and money for drug development for many diseases.

Biosimulation technology offers virtual clinical trial population for pediatric, elderly and other group of patients. It enables to perform better clinical trials and reduce the time and effort for drug discovery and development. Technological advancement and innovation in biosimulation market enables to penetrate in emerging economies such as China, India, Japan and Korea. Biosimulation market by application such as preclinical testing, clinical trials, target identification and validation, lead identification and optimization are enhanced through research and development. Biosimulation market by product includes Pharmacokinetic/Pharmacodynamic (PK/PD), Molecular Modeling, Toxicity Prediction Software. These products enables to avoid drug-drug interaction studies, evaluating, genetic differences, predicting human doses and handling of drugs.

Geographical Insights:

North America generates highest revenues across the globedue to huge adoption of Biosimulation technology and highest rate of healthcare spending followed by Europe. Untapped APAC region such as China, India, Japan and Korea are the most emerging economies and expected to create huge opportunity for Biosimulation Market. Improved healthcare spending, infrastructure development and favorable government policies are the key factors which are expected to drive the APAC market. The report includes detailed Market Overview, Market Determinants, Company Profiling, Market Segmentation, Geographical Analysis, Pipeline Analysis, Strategic Recommendations, Key Company Analysis, Key Findings, Market Insights, Analyst Insights and predictive analysis of the market.

Global Biosimulation Market is expected to grow significantly due to rise in adoption of drug discovery and development, personalized medicine and success of precision dozing. The successful outcome of research & development and critical FDA approvals enable the Biosimulation Market to grow fast. Funding from government and private players are also key factors to drive the Global Biosimulation Market. However, high cost of global Biosimulation products and application are concern for the growth of the market.

Competitive Insights:

The key players of Global Biosimulation Market includes Certara Us, Inc., Simulation Plus Inc.,Dassault Systèmes SA, Schrodinger Inc.,Advanced Chemistry Development, Inc., Chemical Computing Group, Inc., Entelos Holding Corporation, Genedata AG, Physiomics PLC, Rhenovia Pharma Ltd, Accelrys Inc., Leadscope, Insilico Biosciences, Compugen, Nimbus Healthcare, Insilico Biosciences Inc., Inhibox, Johnson & Johnson, Biovia, Leadinvent Technologies and so on. The key strategies adopted by the market players include R&D, partnership, FDA approval, product development, innovation and so on.

Market Segmentation:

Global Biosimulation Market is segmented on the basis of application, product, end user and region. Global Biosimulation Market by application and end user has significant contribution in generating huge revenues across the globe. The Global Biosimulation Market by productsuch as PK/PD modelling and simulation, molecular modelling are widely adopted across the globe. Global simulation market by application such as drug development, preclinical testing, drug discovery and so on. The report includes following segments and sub-segments:

  1. Biosimulation Market Research And Analysis, By Application
    • Drug Development
      • Preclinical Testing
      • Pharmacokinetic/Pharmacodynamic (PK/PD)
      • Adme/Tox
      • Clinical Trials
    • Drug Discovery
      • Target Identification And Validation
      • Lead Identification And Optimization
      • Other Applications


  1. Biosimulation Market Research And Analysis, By Product
    • Software
    • Gastric Cancer
    • Lymphoma
    • Prostate Cancer
    • Non-Small Cell Lung Carcinoma
    • Other Diseases


  1. Biosimulation Market Research And Analysis, By Product
    • Software
      • Pharmacokinetic/Pharmacodynamic (PK/PD)Modeling And Simulation Software
      • Molecular Modeling And Simulation Software
      • Physiologically Based Pharmacokinetic Modeling (PBPM) Modeling And Simulation Software
      • Toxicity Prediction Software
      • Trial Design Software
      • Other Software
    • Service
    • External/Contract Services


  1. Biosimulation Market Research And Analysis, By End User
    • Hospitals
    • Biotechnology and Pharmaceutical Companies
    • Drug Discovery Companies And Drug Development
    • Education Centers And Research Institutes
    • Regulatory Authorities
    • Others
OMR Report covers:
  • Comprehensive research methodology of Global Biosimulation Market.
  • This report also includes detailed and extensive market overview with Analyst insights & key market trends.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Global Biosimulation Market.
  • Insights about market determinants which are stimulating the Global Biosimulation Market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.